Daily Judi: Wednesday, November 23, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
BioPharma Dive take a comprehensive look at the past, present, and future of biotechnology in the Boston region, and biotech's expansion out of Cambridge's Kendall Square neighborhood.
Dr. Naveed Saleh lists four important cancer clinical trials to watch. (MDLinx)
Shoibal Datta, Head of Digital Health Sciences at Takeda, and Jennifer Goldsack, CEO of the Digital Medicine Society, discuss the digital clinical trial landscape, and ways digital innovation may shape new drug development. (Pharmaceutical Executive)
Our Culture
“We work proactively with each client, analyzing our reports to make them work faster, to help make our client’s life better.”
–Tim, Trial Delivery
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
